Quantum Computing News: IBM Unveils New System, Pasqal Sales Plunge 42%
Welcome to Monday’s quantum computing news recap. This edition brings IBM’s first quantum computer deployment in Illinois, a proposed $27 million s...
Abbvie Inc. (ABBV)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 10,063,539 | $2,632,521,480 | +6% | 0.76% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 3,228,135 | $844,447,834 | +8% | 0.74% |
| 3. | Quantinno Capital Hoon Kim | 1,481,001 | $387,415,255 | +31% | 0.37% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 995,151 | $260,321,550 | +17% | 0.11% |
| 5. | 272,400 | $71,257,116 | +349% | 0.07% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.00 | 1,550 | $106,950.00 | 17,644 | 2020-03-20 | Filing | |
| $69.00 | 750 | $51,750.00 | 16,844 | 2020-03-20 | Filing | |
| $67.50 | 800 | $54,000.00 | 16,094 | 2020-03-20 | Filing | |
| $68.18 | 2,200 | $150,004.80 | 15,294 | 2020-03-18 | Filing | |
| $69.00 | 750 | $51,750.00 | 16,844 | 2020-03-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $293.60 | 40,619 | $11,925,738.40 | 83,171 | 2026-11-09 | Filing | |
| $250.00 | 32,710 | $8,177,500.00 | 74,430 | 2026-08-14 | Filing | |
| $233.56 | 5,230 | $1,221,518.80 | 2,654 | 2026-03-04 | Filing | |
| $235.26 | 2,600 | $611,676.00 | 4,619 | 2026-03-02 | Filing | |
| $234.66 | 10,291 | $2,414,886.06 | 7,219 | 2026-03-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 148,974,939 | $38,970,354,223 | 0.57% | |
| 2. | 115,676,728 | $30,259,875,278 | 0.64% | |
| 3. | 82,815,387 | $21,663,677,085 | 0.63% | |
| 4. | 49,001,331 | $12,818,258,176 | 0.58% | |
| 5. | 47,503,777 | $12,404,019,552 | 0.64% |
News See All
10 Best Healthcare and Insurance Stocks To Buy Following the 2026 Democratic Midterm Sweep
Healthcare stocks emerged as some of the clearest beneficiaries of the Democrats' sweeping victory in the November 3 midterm elections, as investors reassessed the outlook for federal healthcare spending...
10 Most Undervalued Dividend Growth Stocks According to Hedge Funds
Dividend-paying stocks can be an important part of a long-term investment portfolio because they let investors earn steady income while also participating in the stock market's growth.
Options Volatility and Implied Earnings Moves Today, October 30, 2026
Today, several major companies are expected to report earnings: BP (BP), Cameco (CCJ), Chevron (CVX), Colgate-Palmolive (CL), Dominion Energy (D), ...
Options Volatility and Implied Earnings Moves This Week, October 26 – October 30, 2026
This week, several major companies will be reporting earnings. Among them are Amazon (AMZN), Microsoft (MSFT), Alphabet Class A (GOOGL), Alphabet C...
The Week That Was, The Week Ahead: Macro and Markets, October 25
U.S. stocks finished Friday lower as rising oil prices and renewed inflation concerns weighed on Wall Street. The Dow Jones Industrial Average (DJI...
Jim Cramer and Ken Fisher Like This Healthcare Stock
With AI stocks making waves, some prudent investors are looking at healthcare names to diversify amid concerns about an AI data center slowdown. AbbVie Inc.
Top 10 Stocks Jim Cramer and Billionaire Ken Fisher Like
Billionaire Ken Fisher and Jim Cramer come from very different worlds. Cramer is the fiery CNBC host who talks fast and keeps the show moving.
AbbVie vs. AstraZeneca: Which Pharma Giant Has the Stronger Earnings Growth Story?
AbbVie Inc. (NYSE:ABBV) and AstraZeneca PLC (NYSE:AZN) are both delivering earnings growth, but their latest results reveal different strengths.
11 Best Cancer Stocks to Invest In Now
Cancer’s Burden Keeps the Search for Better Treatments Urgent For cancer patients, progress means more time, fewer side effects, and a better chance of recovery.
Hedge Fund Resource Center